Annovis Bio, Inc. (ANVS) vs Serina Therapeutics, Inc. (SER)

Annovis Bio, Inc. and Serina Therapeutics, Inc. are both Biotechnology companies. Annovis Bio, Inc. and Serina Therapeutics, Inc. are of similar size ($56.8M and $54.4M). Across the 8 metrics below, Serina Therapeutics, Inc. leads on 6 and Annovis Bio, Inc. on 2.

Valuation

Metric ANVS SER Biotechnology median
P/E n/m n/m 7.88
P/S n/m 189.20 11.47
P/B n/m 1.83 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 95.00 10.73
Earnings yield (136.64%) (90.43%) (28.84%)
Free cash flow yield (88.18%) (61.91%) (23.03%)

Profitability

Metric ANVS SER Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (703.68%) (306.22%) (57.72%)
Return on assets (227.74%) (136.00%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANVS SER Biotechnology median
Revenue growth (TTM) — (94.21%) 5.64%
EPS growth (last fiscal year) 39.39% (26.49%) —
Revenue growth, 5-year CAGR — (18.48%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANVS SER Biotechnology median
Debt to equity 0.00 0.16 0.00
Current ratio 3.47 6.65 4.73
Net debt to EBITDA 0.66 0.00 0.96

Dividend

Metric ANVS SER Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ANVS SER Biotechnology median
Market cap 56.76m 54.36m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack